p53 Regulation Goes Live-Mdm2 and MdmX Co-Star: Lessons Learned from Mouse Modeling

Genes and Cancer

Volumn 3, Issue 3-4, 2012, Pages 219-225

  Tollini, Laura A ^a,b   Zhang, Yanping ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

E3 ubiquitin ligase; Mdm2; MdmX; mouse models; p53

Indexed keywords

PROTEIN MDM2; PROTEIN MDMX; PROTEIN P53; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; DIMERIZATION; DNA DAMAGE; ENZYME ACTIVITY; EXPERIMENTAL MOUSE; GENE INACTIVATION; GENE TARGETING; GENETIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; UBIQUITINATION;

EID: 84875510464     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601912454732     Document Type: Article

References (44)

1. Levine AJ.p53, the cellular gatekeeper for growth and division.Cell. 1997;88:323-31.
2. Hainaut P,Soussi T,Shomer B, et al.Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects.Nucleic Acids Res. 1997;25:151-7.
3. Danovi D,Meulmeester E,Pasini D, et al.Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity.Mol Cell Biol. 2004;24:5835-43.
4. Momand J,Jung D,Wilczynski S,Niland J.The MDM2 gene amplification database.Nucleic Acids Res. 1998;26:3453-9.
5. Ramos YF,Stad R,Attema J,Peltenburg LT,van der Eb AJ,Jochemsen AG.Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53.Cancer Res. 2001;61:1839-42.
6. Deisenroth C,Zhang Y.The ribosomal protein-Mdm2-p53 pathway and energy metabolism: bridging the gap between feast and famine.Genes Cancer. 2011;2:392-403.
7. Levine AJ,Tomasini R,McKeon FD,Mak TW,Melino G.The p53 family: guardians of maternal reproduction.Nat Rev Mol Cell Biol. 2011;12:259-65.
8. Lane D,Levine A.p53 research: the past thirty years and the next thirty years.Cold Spring Harb Perspect Biol. 2010;2:a000893.
9. Momand J,Zambetti GP,Olson DC,George D,Levine AJ.The Mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.Cell. 1992;69:1237-45.
10. Wu X,Bayle JH,Olson D,Levine AJ.The p53-Mdm-2 autoregulatory feedback loop.Genes Dev. 1993;7:1126-32.
11. Lin J,Chen J,Elenbaas B,Levine AJ.Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to Mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes Dev. 1994;8:1235-46.
12. Yang Y,Li CC,Weissman AM.Regulating the p53 system through ubiquitination.Oncogene. 2004;23:2096-106.
13. Leng RP,Lin Y,Ma W, et al.Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.Cell. 2003;112:779-91.
14. Dornan D,Wertz I,Shimizu H, et al.The ubiquitin ligase COP1 is a critical negative regulator of p53.Nature. 2004;429:86-92.
15. Rajendra R,Malegaonkar D,Pungaliya P, et al.Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.J Biol Chem. 2004;279:36440-4.
16. Shvarts A,Steegenga WT,Riteco N, et al.MDMX: a novel p53-binding protein with some functional properties of MDM2.EMBO J. 1996;15:5349-57.
17. Jackson MW,Berberich SJ.MdmX protects p53 from Mdm2-mediated degradation.Mol Cell Biol. 2000;20:1001-7.
18. Poyurovsky MV,Priest C,Kentsis A, et al.The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity.EMBO J. 2007;26:90-101.
19. Jones SN,Roe AE,Donehower LA,Bradley A.Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.Nature. 1995;378:206-8.
20. Montes de Oca Luna R,Wagner DS,Lozano G.Rescue of early embryonic lethality in Mdm2-deficient mice by deletion of p53.Nature. 1995;378:203-6.
21. Parant J,Chavez-Reyes A,Little NA, et al.Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.Nat Genet. 2001;29:92-5.
22. Terzian T,Wang Y,Van Pelt CS,Box NF,Travis EL,Lozano G.Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.Mol Cell Biol. 2007;27:5479-85.
23. Marine JC,Francoz S,Maetens M,Wahl G,Toledo F,Lozano G.Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.Cell Death Differ. 2006;13:927-34.
24. Honda R,Tanaka H,Yasuda H.Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.FEBS Lett. 1997;420:25-7.
25. Itahana K,Mao H,Jin A, et al.Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.Cancer Cell. 2007;12:355-66.
26. Huang L,Yan Z,Liao X, et al.The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo.Proc Natl Acad Sci U S A. 2011;108:12001-6.
27. Pant V,Xiong S,Iwakuma T,Quintas-Cardama A,Lozano G.Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability.Proc Natl Acad Sci U S A. 2011;108:11995-2000.
28. Wang Y,Suh YA,Fuller MY, et al.Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation.J Clin Invest. 2011;121:893-904.
29. Tanimura S,Ohtsuka S,Mitsui K,Shirouzu K,Yoshimura A,Ohtsubo M.MDM2 interacts with MDMX through their RING finger domains.FEBS Lett. 1999;447:5-9.
30. Kostic M,Matt T,Martinez-Yamout MA,Dyson HJ,Wright PE.Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53.J Mol Biol. 2006;363:433-50.
31. Linke K,Mace PD,Smith CA,Vaux DL,Silke J,Day CL.Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans.Cell Death Differ. 2008;15:841-8.
32. Marine JC,Jochemsen AG.Mdmx as an essential regulator of p53 activity.Biochem Biophys Res Commun. 2005;331:750-60.
33. Li C,Chen L,Chen J.DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms.Mol Cell Biol. 2002;22:7562-71.
34. Uldrijan S,Pannekoek WJ,Vousden KH.An essential function of the extreme C-terminus of MDM2 can be provided by MDMX.EMBO J. 2007;26:102-12.
35. Hashizume R,Fukuda M,Maeda I, et al.The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.J Biol Chem. 2001;276:14537-40.
36. Fang S,Jensen JP,Ludwig RL,Vousden KH,Weissman AM.Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.J Biol Chem. 2000;275:8945-51.
37. Honda R,Yasuda H.Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.Oncogene. 2000;19:1473-6.
38. Di Conza G,Mancini F,Buttarelli M,Pontecorvi A,Trimarchi F,Moretti F.MDM4 enhances p53 stability by promoting an active conformation of the protein upon DNA damage.Cell Cycle. 2012;11:749-60.
39. Biderman L,Poyurovsky MV,Assia Y,Manley JL,Prives C.MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress.Mol Cell Biol. 2012;32:1214-25.
40. de Graaf P,Little NA,Ramos YF,Meulmeester E,Letteboer SJ,Jochemsen AG.Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2.J Biol Chem. 2003;278:38315-24.
41. Kawai H,Wiederschain D,Kitao H,Stuart J,Tsai KK,Yuan ZM.DNA damage-induced MDMX degradation is mediated by MDM2.J Biol Chem. 2003;278:45946-53.
42. Pan Y,Chen J.MDM2 promotes ubiquitination and degradation of MDMX.Mol Cell Biol. 2003;23:5113-21.
43. Wade M,Li YC,Matani AS, et al.Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.Oncogene. 2012;:.
44. O'Brate A,Giannakakou P.The importance of p53 location: nuclear or cytoplasmic zip code?.Drug Resist Updat. 2003;6:313-22.